🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Clinical

Exercise Echocardiography Registry for Ischemic and Non-Ischemic Heart Disease NCT07367893n/a1 site📍 Yongin Yonsei University Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. NCT07044921Phase 21 site📍 Beijing Chinese PLA General Hospital · Tests: Irinotecan Liposomes (II)+Cetuximab+Bevacizumabl Efficacy and Safety of Anlotinib Combined With Bemocizumab for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma(ESCC) NCT07627347NA1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: anlotinib+bevacizumab A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site📍 Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care NCT05391126NA1 site📍 Lexington Reema A. Patel · Tests: Irinotecan Single-Lead ECG Conduction Interval Algorithm NCT07667465n/a1 site📍 Hangzhou Vivalink Nephrotic Syndrome Study Network NCT01209000n/a44 sites📍 Los Angeles📍 Palo Alto📍 San Francisco University of Michigan · Tests: Kidney Biopsy IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors NCT05958121Phase 1, Phase 229 sites📍 Heidelberg📍 Heidelberg📍 Mannheim Immatics Biotechnologies GmbH · Tests: IMA402, IMA402 and checkpoint inhibitor, IMA402 and chemotherapy, IMA402 and IMA401, IMA402 and monoclonal antibody LISA Post Market Clinical Follow-Up Study: Documentation of Clinical Outcomes After Surgery With LISA Implant NCT04631133n/a5 sites📍 Silkeborg📍 Bordeaux📍 Lyon BACKBONE · Tests: Lumbar Implant for Stiffness Augmentation (LISA) AMBulatory UltraSound for Heart Failure Management NCT04741711NA5 sites📍 Besançon📍 Mulhouse📍 Reims Central Hospital, Nancy, France · Tests: An ultrasound (lung and inferior vena cava) will be performed and the heart failure treatments will be guided by the re… A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care NCT06538064n/a15 sites📍 Rancho Mirage📍 San Francisco📍 New Haven Takeda · Tests: No Intervention Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder NCT07420816Phase 21 site📍 Bragança Paulista Apsen Farmaceutica S.A. · Tests: APSTZD 1, APSTZD 2, APSTZD 3, APSTZD 4, Stilnox CR® The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients NCT06503016Phase 31 site📍 Milan Università Vita-Salute San Raffaele · Tests: Phosphocreatine, Placebo An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease NCT06272149EARLY Phase 11 site📍 Shanghai Xinhua Hospital, Shanghai Jiao Tong University School of Me… · Tests: VGN-R08b A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency NCT07347249Phase 21 site📍 London Hemab ApS · Tests: Sutacimig, Sutacimig Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC NCT06929936Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Trilaciclib combined with Docetaxel Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy NCT07361471NA1 site📍 Clermont-Ferrand Centre Jean Perrin · Tests: molecular analysis PENG Block & PENG PRF NCT07360093n/a1 site📍 Ankara Ankara City Hospital Bilkent · Tests: PENG Block Pulsed radiofrequency Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System NCT05493514n/a1 site📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: Robotic Assisted Gait Training with G-EO system Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence NCT06954116Phase 21 site📍 Wuhan Tongji Hospital · Tests: Iparomlimab and Tuvonralimab (QL1706), Partial hepatectomy Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin NCT05467033Phase 31 site📍 Bialystok Medical University of Bialystok · Tests: Desmopressin, intravenous infusion NaCl Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC NCT05941338Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Tirelizumab ,+Carboplatin+albumin-bound paclitaxel Near Infrared Spectroscopy (NIRS) for Assessment of Depression NCT04061148NA1 site📍 San Francisco University of California, San Francisco · Tests: NIRSIT Phase III Study of OT202 in Treating Moderate to Severe Dry Eye NCT07740564Phase 349 sites📍 Bengbu📍 Hefei📍 Beijing Ocumension Therapeutics (Suzhou) Co., Ltd · Tests: OT202 conc 1%, Placebo Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL NCT07244406Phase 21 site📍 Beijing Hebei Senlang Biotechnology Inc., Ltd. · Tests: S1904 CD19 CAR-T Effect of ANKASCIN 568-P Products Regulating Blood Lipid NCT05737355NA1 site📍 Taipei SunWay Biotech Co., LTD. · Tests: ANKASCIN 568-P Red yeast rice capsules, Placebo Capsules A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis NCT07499700Phase 2, Phase 31 site📍 Beijing Bio-Thera Solutions · Tests: BAT4406F, Placebos A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM NCT06976606n/a6 sites📍 Redwood City📍 Baltimore📍 Columbia Lexeo Therapeutics Evaluating the Efficacy of "Digestive Aid" in Functional Dyspepsia NCT06958952NA1 site📍 Tehran Tehran University of Medical Sciences · Tests: Digestive Aid, Placebo ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site📍 Liverpool Pierian Biosciences · Tests: No intervention
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy